RGIN.US Regenicin Inc.

Healthcare Biotechnology USA Stocks
0.0001 USD
Close of Oct 17, 2026
0.0001 0.0005
Market cap
USD 15.3K
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 4 quarters up to Sep 2023.

Is RGIN.US undervalued?

Graham number

The Graham number of Regenicin Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Regenicin Inc. fundamental analysis

No fundamental analysis for Regenicin Inc. yet.

Regenicin Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Regenicin Inc.

Regenicin, Inc., a biotechnology company, develops regenerative cell therapies to restore the health of damaged tissues and organs. Its product includes Tiscela, a tissue-engineered skin graft that utilizes a patient's own skin cells to create living, regenerative skin for treating severe burns and chronic wounds. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartere…

Full company profile